GordonMD Global Investments LP
Reporting owner on Forms 3, 4 and 5, CIK 2039349.
- Also a 13F filer: GordonMD Global Investments LP
- In the filer group GordonMD Global Investments LP
GordonMD Global Investments LP reported on 1 issuer in 7 filings, the latest a 13G/A filed 2026-10-09.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Pyxis Oncology, Inc. CIK 1782223 | 10% owner | 2 | 2026-10-09 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PYXS · Pyxis Oncology, Inc.Common Stock Purchase Warrant, derivative | 2026-10-01 | P bought | +7,172,000 | 7,172,000 | Form 4/A | |
| Pyxis Oncology, Inc. Common Stock, par value $0.001 per shar…, superseded by an amendment | 2026-10-01 | P bought | +5,517,000 | 15,541,909 | Form 4 | |
| Pyxis Oncology, Inc. Common Stock Purchase Warrant, derivative, superseded by an amendment | 2026-10-01 | P bought | +7,546,766 | 7,546,766 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13G/A 0000919574-26-006818 | PYXS | 2026-10-09 | ||
| Form 4/A 0000919574-26-006815 | Pyxis Oncology, Inc. | 2026-10-09 | ||
| Form 4 0000919574-26-006609 | Pyxis Oncology, Inc. | 2026-10-02 | ||
| 13G/A 0000919574-26-006608 | PYXS | 2026-10-02 | ||
| 13F-HR 0000919574-26-005398 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000919574-26-003273 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000919574-26-001152 | Quarter ended 2025-12-31 | 2026-02-17 | acceptance time not in the bulk data set |